The 2nd Summit Forum on Innovative Drug Research (and Development of Antiviral Drugs) was held in Xiasha, Hangzhou from October 30 to 31, 2020, with a scale of 300 + people.The new coronavirus (COVID-19) spread worldwide in 2020. On January 30, the World Health Organization (WHO) declared that the new coronavirus outbreak constituted an "public health emergency of international concern" and issued the highest-level alert of the organization.In the face of the sudden outbreak, scientific researchers around the world are day by day deciphering the structure of the new coronavirus and studying therapeutic drugs.
Guest group photo
The 2nd Summit Forum on Innovative Drug Research (and Antiviral Drug Development) invited academician Jiang Hualiang, Chinese Academy of Sciences, Rao Zi, Academician of Chinese Academy of Sciences, Professor Jiang Shibo, Fudan University, Professor Li Bin, Shanghai Institute of Immunology, Shanghai Jiaotong University School of Medicine, Professor Yu Sheng, Director of State Key Laboratory of Life Organic Chemistry,Professor Tao Shengze, President, Dr. Zhu Yonghong of Roche R&D (China) Co., Ltd., Dr. Shao Zheng, founder of Aike Baifa, Senior Vice President of Frontier Biology Lu Rongjian and Dr. Wu Jinzi, founder of Geli, researcher of Yan Huimin of National Key Laboratory of Virology, and well-known experts in the field of antiviral research, such as Dr. Liu Xiaoyu, founder of Chengdu Fanosi, will continue to open up antiviral drugs.Send you a deep dialogue and communication.
Jiang Hualiang, Academician of Chinese Academy of Sciences
Zhou Qilin, Academician of Chinese Academy of Sciences
Shi Huamiao, Deputy Secretary of the Party and Labor Committee and Executive Vice Director of the Management Committee of Qiantang New Area, Hangzhou
Chen Kui, Deputy Director-General of Zhejiang Provincial Drug Administration
Hangzhou GoTop Biotech Co., Ltd. (Left Shen Yonggang, Right Jiang Shibo)
In his opening speech, Zhou Qilin, academician of the Chinese Academy of Sciences, said that under the background of the global new crown epidemic, it is a great event for academic circles to enable antiviral drug experts to share cutting-edge information with each other, inspire innovative thinking and stimulate innovative ideas through this forum.
Jiang Shibo, director of the Institute of Pathogenic Microorganisms of Fudan University, has been engaged in the research of antiviral drugs and vaccines for many years, and is one of the earliest international researchers involved in the research and development of anti-HIV.
At this meeting, Professor Jiang delivered a speech entitled "Universal Coronavirus Fusion Inhibitors - Combating New and Reproducible Coronavirus Epidemics".
Professor Jiang said that broad-spectrum anti-crown polypeptide is one of the best weapons for prevention and control of the new crown epidemic, and has the characteristics of easy scale production, low production cost and easy transportation.Professor Jiang said: "Current research and development of new coronavirus is ma...
(All Rights Reserved)